SP Scientific Products (SP) announces that to stay ahead of the ever-increasing global demand for its state-of-the-art fill-finish and lyophilization (freeze dryer) equipment, it has more than doubled its worldwide manufacturing capacity. Central to this expansion is the opening of a new large-scale manufacturing facility in Barcelona, Spain, for SP i-Dositecno sterile fill-finish systems. SP is also increasing its manufacturing headcount and streamlining many of its manufacturing processes. These strategic advancements are already ensuring reduced order-to-delivery lead times for its advanced aseptic pharmaceutical processing equipment.
SP now delivers the world’s largest installation of commercial freeze dryers for SARS-CoV-2 diagnostics production. To further reduce lead times, SP is significantly building its global manufacturing workforce with the recruitment of quality and electrical engineers, project managers and production staff, as well as field service engineers to install and maintain the many new SP systems.
The new 4000m2 facility in Barcelona has been built alongside its original factory, delivering a 100% increase in manufacturing space. Systems are already being built at the new facility and include SP’s modular sterile filling, stoppering and capping machines, such as its SP i-Dositecno Versa-Lines, Micro-Lines, Flexi-Lines and Ophtha-Lines. These are ideal for the lower-volume requirements of the growing number of biologic drugs for smaller patient groups - a key factor in the increased demand for SP’s highly configurable fill-finish and lyophilization equipment.
“Our highly flexible fill-finish and lyophilization modules mean that we can deliver a complete system engineered for specific customer needs in a matter of weeks, even for our most complex units, whilst remaining cost-competitive,” said Brian Larkin, President and Chief Executive Officer, SP Industries. “It’s why SP is increasingly seen by pharma and diagnostic companies as a go-to provider, particularly for small batch manufacturing systems. We’re continuing to make these major investments in capacity, such as the opening of our new SP Barcelona facility, to ensure that we can continue driving down lead times, even as we deliver an increasing number of units. This, in turn, enables our customers to get their products to market sooner.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!